Sunny Al-Shamma
Vorstandsvorsitzender bei Beacon Discovery, Inc.
Profil
Sunny Al-Shamma currently works at Eurofins Panlabs, Inc., as President & Chief Executive Officer and Beacon Discovery, Inc., as President, Chairman & Chief Executive Officer.
Aktive Positionen von Sunny Al-Shamma
| Unternehmen | Position | Beginn |
|---|---|---|
Beacon Discovery, Inc.
 Beacon Discovery, Inc. BiotechnologyHealth Technology Beacon Discovery, Inc. is a world leader in GPCR-focused drug discovery. The private company is based in San Diego, CA. The company's mission is to efficiently identify and advance molecules targeting GPCRs from concept to clinic. In addition, Beacon collaborates with biopharma partners to leverage internally enabled GPCR targets and small molecule modulators as well as its wealth of GPCR discovery skills and tools. The CEO of the company is Sunny Al-Shamma. | Vorstandsvorsitzender | - |
Eurofins Panlabs, Inc.
 Eurofins Panlabs, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Eurofins Scientific SE, Eurofins Panlabs, Inc. is a company that provides molecular pharmacology, functional pharmacology, cellular services and informatics analytics. The company is based in Saint Charles, MO. The company was founded in 2012. The CEO is Sunny Al-Shamma. | Vorstandsvorsitzender | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Eurofins Panlabs, Inc.
Eurofins Panlabs, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Eurofins Scientific SE, Eurofins Panlabs, Inc. is a company that provides molecular pharmacology, functional pharmacology, cellular services and informatics analytics. The company is based in Saint Charles, MO. The company was founded in 2012. The CEO is Sunny Al-Shamma. | Commercial Services |
Beacon Discovery, Inc.
Beacon Discovery, Inc. BiotechnologyHealth Technology Beacon Discovery, Inc. is a world leader in GPCR-focused drug discovery. The private company is based in San Diego, CA. The company's mission is to efficiently identify and advance molecules targeting GPCRs from concept to clinic. In addition, Beacon collaborates with biopharma partners to leverage internally enabled GPCR targets and small molecule modulators as well as its wealth of GPCR discovery skills and tools. The CEO of the company is Sunny Al-Shamma. | Health Technology |